(Q40181528)

18 September 2017

Evidence for intercellular trafficking of VP22 in living cells (English)

1 reference

18 September 2017

Marie-Luise Lemken

1

1 reference

18 September 2017

Claudia Wolf

2

1 reference

18 September 2017

Wolfgang A Wybranietz

3

1 reference

18 September 2017

Ulrike Schmidt

4

1 reference

18 September 2017

Irina Smirnow

5

1 reference

18 September 2017

Hans-Joerg Bühring

6

1 reference

18 September 2017

Andreas F Mack

7

1 reference

18 September 2017

Ulrich M Lauer

8

1 reference

18 September 2017

Michael Bitzer

9

1 reference

18 September 2017

1 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

15

1 reference

18 September 2017

2

1 reference

18 September 2017

310-319

1 reference

The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49

18 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular trafficking and protein delivery by a herpesvirus structural protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular trafficking of VP22-GFP fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Bovine herpesvirus tegument protein VP22 enhances thymidine kinase/ganciclovir suicide gene therapy for neuroblastomas compared to herpes simplex virus VP22.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Evaluation of strategies for the intracellular delivery of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Evaluation of VP22 spread in tissue culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Is VP22 nuclear homing an artifact?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Positively charged DNA-binding proteins cause apparent cell membrane translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Cell surface adherence and endocytosis of protein transduction domains.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

A genetic immunization adjuvant system based on BVP22-antigen fusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

"Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Methods for construction of adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300013

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300013

1 reference

18 September 2017

1 reference